Lamictal May Have Small Benefit for Bipolar Depression
The Carlat Psychiatry Report, Volume 7, Number 4, April 2009
https://www.thecarlatreport.com/newsletter-issue/tcprv7n4/
Issue Links: Learning Objectives | Editorial Information
Topics: Bipolar Disorder
Section editor, Glen Spielmans, PhD
Researchers (not paid by the drug company) examined data from GlaxoSmithKline’s database of clinical trials for lamotrigine (Lamictal) as a treatment for bipolar depression.
You can't view details of this content, please login or buy subscription here
Section editor, Glen Spielmans, PhD
Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.